Insulet Corp. (PODD) Return on Invested Capital (ROIC): 13.62%
Is Insulet Corp.’s return on invested capital (ROIC) high or low?
Insulet Corp.'s return on invested capital (ROIC) of 13.62% is 87% above its 5-year average of 7.27%, near the high end of its 5-year range (0.92%–13.62%).
As of Thursday, June 25, 2026. 7.67% above its 12-month average of 12.65%.
PODD Return on Invested Capital (ROIC) Chart
Reported annual fiscal-period values; no daily interpolation.
PODD Average Return on Invested Capital (ROIC) Chart
PODD Current vs Average Return on Invested Capital (ROIC) Chart
PODD Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
13.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
12.65%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
2.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-3.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-3.02%
CURRENT VS TTM AVG
+7.67%
CURRENT VS 3Y AVG
+51.84%
CURRENT VS 5Y AVG
+87.43%
CURRENT VS 10Y AVG
+537.80%
CURRENT VS 15Y AVG
+460.26%
CURRENT VS 20Y AVG
+550.32%
PODD Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 13.62% | 12.65% | 8.97% | 7.27% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -24.28% | -15.13% | -6.38% | -2.73% |
| Baxter International Inc. (BAX)vs › | $10.87B | -1.79% | -0.86% | -2.61% | 0.30% |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | 8.36% | 4.65% | 6.09% | 6.66% |
| Henry Schein, Inc. (HSIC)vs › | $9.38B | 6.58% | 6.66% | 7.75% | 8.24% |
| Revvity, Inc. (RVTY)vs › | $11.78B | 2.82% | 2.97% | 3.42% | 5.50% |
| Align Technology, Inc. (ALGN)vs › | $12.24B | 9.94% | 9.96% | 10.13% | 11.66% |
| Solventum Corporation (SOLV)vs › | $13.01B | 17.76% | 12.30% | 11.68% | 9.70% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 2.04% | 2.21% | 2.35% | 2.39% |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | -27.10% | -12.21% | -19.73% | -18.73% |
Capital Efficiency
ROIC
13.6%
ROE
23.3%
Insulet Corp. Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Insulet Corp. Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The return on invested capital (ROIC) for PODD stock is 13.62%.
- Is Insulet Corp.'s return on invested capital (ROIC) high or low?
- Insulet Corp.'s return on invested capital (ROIC) of 13.62% is 87% above its 5-year average of 7.27%, near the high end of its 5-year range (0.92%–13.62%).
- What is the TTM average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The TTM average return on invested capital (ROIC) for PODD stock is 12.65%.
- What is the 3Y average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The 3Y average return on invested capital (ROIC) for PODD stock is 8.97%.
- What is the 5Y average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The 5Y average return on invested capital (ROIC) for PODD stock is 7.27%.
- What is the 10Y average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The 10Y average return on invested capital (ROIC) for PODD stock is 2.14%.
- What is the 15Y average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The 15Y average return on invested capital (ROIC) for PODD stock is -3.78%.
- What is the 20Y average return on invested capital (ROIC) for Insulet Corp. (PODD)?
- The 20Y average return on invested capital (ROIC) for PODD stock is -3.02%.
Insulet Corp. Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 13.62% |
| 2024-12-31 | 11.68% |
| 2023-12-31 | 9.66% |
| 2022-12-31 | 0.92% |
| 2021-12-31 | 5.58% |
| 2020-12-31 | 2.14% |
| 2019-12-31 | 4.05% |
| 2018-12-31 | 2.14% |
| 2017-12-31 | -1.01% |
| 2016-12-31 | -2.67% |
| 2015-12-31 | -22.62% |
| 2014-12-31 | -3.40% |
| 2013-12-31 | -11.74% |
| 2012-12-31 | -21.91% |
| 2011-12-31 | -18.79% |
| 2010-12-31 | -28.14% |
| 2009-12-31 | -39.09% |
| 2008-12-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2004-12-31 | 667.91% |
| 2003-12-31 | 0.00% |
| 2002-12-31 | 0.00% |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy